Author:
Kruijtzer C.M.F.,Boot H.,Beijnen J.H.,Lochs H.L.,Parnis F.X.,Planting A.S.T.,Pelgrims J.M.G.,Williams R.,Mathôt R.A.A.,Rosing H.,Schot M.E.,van Tinteren H.,Schellens J.H.M.
Reference35 articles.
1. Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer;Cullinan;J Clin Oncol,1994
2. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin. A step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group;Wils;J Clin Oncol,1991
3. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer;Webb;J Clin Oncol,1997
4. Epirubicin, cisplatin and continuous 5-FU chemotherapy (ECF-regimen) in patients with cancer of the gastroesophageal junction and stomach;Boot;Gastroenterology,2002
5. An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer;Ohtsu;Am J Clin Oncol,1998
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献